| Primary |
| Weight Decreased |
17.7% |
| Increased Appetite |
13.5% |
| Decreased Appetite |
12.0% |
| Breast Cancer |
7.8% |
| Cachexia |
5.2% |
| Anorexia |
4.7% |
| Hypertension |
4.7% |
| Endometrial Cancer |
4.2% |
| Lung Neoplasm Malignant |
4.2% |
| Metastatic Gastric Cancer |
3.1% |
| Metastatic Malignant Melanoma |
3.1% |
| Diabetes Mellitus |
2.6% |
| Weight Increased |
2.6% |
| Appetite Disorder |
2.1% |
| Arthritis |
2.1% |
| Asthma |
2.1% |
| Dementia |
2.1% |
| Neoplasm Malignant |
2.1% |
| Ovarian Cancer |
2.1% |
| Prostate Cancer |
2.1% |
|
| Death |
35.8% |
| Malignant Neoplasm Progression |
11.8% |
| Deep Vein Thrombosis |
8.6% |
| Weight Increased |
6.4% |
| Vomiting |
4.3% |
| Lung Neoplasm Malignant |
3.7% |
| Thrombosis |
3.7% |
| Nausea |
2.7% |
| Pulmonary Embolism |
2.7% |
| Weight Decreased |
2.7% |
| Oedema |
2.1% |
| Sepsis |
2.1% |
| Vaginal Haemorrhage |
2.1% |
| Addison's Disease |
1.6% |
| Blood Glucose Increased |
1.6% |
| Confusional State |
1.6% |
| Drug Ineffective |
1.6% |
| Hyperglycaemia |
1.6% |
| Hyperthyroidism |
1.6% |
| Ischaemic Stroke |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
21.7% |
| Decreased Appetite |
12.0% |
| Metastatic Malignant Melanoma |
10.0% |
| Hormone Replacement Therapy |
8.8% |
| Arthritis |
6.7% |
| Drug Use For Unknown Indication |
5.0% |
| Hypertension |
4.7% |
| Depression |
3.8% |
| Iron Deficiency |
3.5% |
| Prophylaxis |
3.2% |
| Nausea |
2.9% |
| Appetite Disorder |
2.6% |
| Chemotherapy |
2.3% |
| Endometrial Cancer |
2.1% |
| Constipation |
1.8% |
| Diabetes Mellitus |
1.8% |
| Disease Progression |
1.8% |
| Pain |
1.8% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Renal Cancer |
1.8% |
|
| Confusional State |
8.1% |
| Pulmonary Embolism |
8.1% |
| Vaginal Haemorrhage |
8.1% |
| Vomiting |
8.1% |
| Death |
6.8% |
| Weight Decreased |
6.8% |
| Breast Cancer Female |
5.4% |
| Thrombocytopenia |
5.4% |
| Abdominal Pain |
4.1% |
| Anaemia |
4.1% |
| Fatigue |
4.1% |
| Hallucination |
4.1% |
| Pulmonary Oedema |
4.1% |
| Somnolence |
4.1% |
| Toxic Skin Eruption |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Breast Cancer |
2.7% |
| Hypotension |
2.7% |
| Malaise |
2.7% |
| Malignant Neoplasm Progression |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.4% |
| Product Used For Unknown Indication |
18.6% |
| Non-small Cell Lung Cancer |
8.4% |
| Pain |
6.0% |
| Multiple Myeloma |
5.3% |
| Prophylaxis |
5.2% |
| Hypertension |
4.7% |
| Nausea |
3.6% |
| Decreased Appetite |
3.3% |
| Constipation |
3.1% |
| Breast Cancer |
3.1% |
| Diabetes Mellitus |
2.4% |
| Metastases To Bone |
2.4% |
| Breast Cancer Metastatic |
2.1% |
| Hepatic Neoplasm Malignant |
2.0% |
| Prostate Cancer |
1.9% |
| Colorectal Cancer Metastatic |
1.8% |
| Vomiting |
1.7% |
| Depression |
1.6% |
| Arthralgia |
1.5% |
|
| Weight Decreased |
14.7% |
| Vomiting |
13.6% |
| Pneumonia |
9.3% |
| Death |
8.6% |
| Thrombocytopenia |
6.3% |
| Sepsis |
5.4% |
| Renal Failure Acute |
5.1% |
| Urinary Tract Infection |
5.0% |
| Renal Failure |
4.1% |
| Dyspnoea |
3.1% |
| Pulmonary Embolism |
3.0% |
| Arthralgia |
2.8% |
| White Blood Cell Count Decreased |
2.8% |
| Tooth Extraction |
2.7% |
| Pancytopenia |
2.6% |
| Hypotension |
2.5% |
| Pyrexia |
2.3% |
| Pleural Effusion |
2.0% |
| Syncope |
2.0% |
| Wound Dehiscence |
2.0% |
|
| Interacting |
| Neoplasm Malignant |
100.0% |
|
| International Normalised Ratio Abnormal |
100.0% |
|
